Pharmafile Logo
Pharmafocus logo
Advanced Search

Allergan

Showing 15 posts of 142 posts found.

allergan

Almirall picks up Allergan’s dermatology portfolio to for $650m

August 3, 2018
Medical Communications, Sales and Marketing Allergan, Almirall, dermatology, pharma

Allergan has sealed a deal to sell its dermatology portfolio, comprising five brands, to Spanish pharmaceutical firm Almirall for $650 …

News

Allergan sues Pfizer over opioid crisis lawsuits

August 3, 2018
Medical Communications Allergan, Litigation, Pfizer, lawsuits, opioid crisis, opioids

Allergan are suing American pharma giant Pfizer over potential damages that they may be forced to pay relating to hundreds …

News
allergan

US court overturns Allergan’s controversial attempts to avoid Restasis patent review

July 23, 2018
Sales and Marketing Allergan, Mylan, Restasis, US, dry eye, pharma

The US Court of Appeals for the Federal Circuit has seen fit to authorise a US Patent and Trademark Office …

News
allergan

Allergan appoints ex-Abbott exec in “Board refreshment” move

June 15, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, Allergan, appointment, pharma

Allergan has announced another move in its “refreshment” of its executive Board of Directors with the appointment of Thomas C …

News
allergan

Allergan’s atogepant fulfils primary endpoint in episodic migraine

June 12, 2018
Manufacturing and Production, Research and Development Allergan, atogepant, migraine, pharma

Allergan has made ground in its quest to become “the headache company” with the release of new Phase 2b/3 data …

News
allergan-irvine-california-2_0

Allergan mauled by investors in public letter

June 6, 2018
Medical Communications, Research and Development Allergan

Last week, Allergan announced that a strategic review of its operations had led to a decision to divest its women’s …

News
shutterstock_273326141

Axovant snatches Teva and Allergan execs to strengthen management

June 5, 2018
Manufacturing and Production, Medical Communications Allergan, Axovant, Teva, appointment, pharma

Axovant has announced reinforcements to its management team with two new additions, snatching up Allergan’s current Chief Medical Officer Dr …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 1, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Allergan, AstraZeneca, Cancer, Gilead, HIV, J&J, JJ, google, machine learning, melanoma, pharma, top ten

The first day of June – time for another top ten run-down. It’s been a week somewhat characterised by trial …

News
allergan-westport-ireland_web

Allergan aims to appease investors with non-core units sell off

May 31, 2018
Medical Communications Allergan, biotech, drugs, pharma, pharmaceutical

Allergan’s share price has been on a steady downward trajectory for the last year and investors are becoming increasingly frustrated …

News
allergan

Allergan recalls 170,000 birth control packs in US over pregnancy fears

May 30, 2018
Research and Development Allergan, FDA, Taytulla, US, birth control, pharma

Allergan has issued a voluntary recall of its birth control medication in the US marketplace after an error in packaging …

News
headache

Amgen/Novartis potential blockbuster migraine med gets FDA nod

May 18, 2018
Medical Communications, Sales and Marketing Allergan, Amgen, Novartis, biotech, drugs, migraine, pharma, pharmaceutical

The first in a new class of migraine treatments has just received approval from the FDA; Amgen and Novartis’ Aimovig …

News
allergan

Allergan unveils second bout of Phase 3 success in migraine

April 30, 2018
Research and Development, Sales and Marketing Allergan, migraine, pharma, ubrogepant

Allergan has revealed new data from the second of two Phase 3 studies into the efficacy of its calcitonin gene-related …

News

Allergan out but Takeda sticks to guns on Shire

April 20, 2018
Medical Communications, Sales and Marketing Allergan, Shire, Takeda, biotech, drugs, pharma, pharmaceutical

Allergan performed an odd about-turn after initially declaring its interest in pursuing a deal for Shire, before reneging on that …

News
top_ten

Top Ten most popular articles on Pharmafile.com this week

April 6, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Boehringer Ingelheim, Kite, Nordic Nanovector, Pfizer, Roche, Sanofi, biotech, cystic fibrosis, drugs, pharma, pharmaceutical

Some of the biggest news this week concerns companies that are looking to move on parts of their business, but …

News

Rumours Allergan is looking to offload $5bn women’s health unit

April 3, 2018
Manufacturing and Production, Sales and Marketing Allergan, Restasis, biotech, drugs, pharma, pharmaceutical

According to a piece by Bloomberg, Allergan is looking at options to divest its women’s health unit in a move …

News

Latest content

FDA accepts new drug application for Orexo’s opioid overdose medication

November 28, 2023

Arcturus Therapeutics gains FDA ODD for cystic fibrosis treatment

November 28, 2023

Sanofi and Regeneron share results from phase 3 trial for Dupixent as COPD treatment

November 27, 2023

GSK shares results from phase 3 trial for Blenrep as multiple myeloma treatment

November 27, 2023

Alladapt Immunotherapeutics gains FDA Fast Track Designation for ADP101 as food allergy treatment

November 24, 2023